Literature DB >> 11918549

Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.

Alessandro Pecci1, Patrizia Noris, Rosangela Invernizzi, Anna Savoia, Marco Seri, Gian Marco Ghiggeri, Saverio Sartore, Simone Gangarossa, Nicola Bizzaro, Carlo L Balduini.   

Abstract

May-Hegglin anomaly (MHA), Sebastian syndrome (SBS) and Fechtner syndrome (FTNS) are autosomal-dominant macrothrombocytopenias with Döhle-like leucocyte inclusions. These diseases are due to mutations of the MHY9 gene, encoding the heavy chain of non-muscle myosin IIA (NMMHC-A). We investigated the NMMHC-A localization in blood cells from eight MHA, SBS or FTNS patients with known MYH9 mutations. All the patients showed an altered localization of NMMHC-A in granulocytes and platelets, suggesting that Döhle-like bodies are due to the aggregation of NMMHC-A in the cytoplasm. Therefore, immunocytochemistry for NMMHC-A is a simple and sensitive method to detect pathological phenotypes of granulocytes and platelets in the diagnosis of MYH9-related disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918549     DOI: 10.1046/j.1365-2141.2002.03385.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.

Authors:  Yingfan Zhang; Mary Anne Conti; Daniela Malide; Fan Dong; Aibing Wang; Yelena A Shmist; Chengyu Liu; Patricia Zerfas; Mathew P Daniels; Chi-Chao Chan; Elliot Kozin; Bechara Kachar; Michael J Kelley; Jeffrey B Kopp; Robert S Adelstein
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

2.  Renal manifestations of patients with MYH9-related disorders.

Authors:  Kyoung Hee Han; HyunKyung Lee; Hee Gyung Kang; Kyung Chul Moon; Joo Hoon Lee; Young Seo Park; Il Soo Ha; Hyo Seop Ahn; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-01-06       Impact factor: 3.714

Review 3.  Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.

Authors:  Oriana Miltiadous; Ming Hou; James B Bussel
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

4.  Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

Authors:  Alessandro Pecci; Ginevra Biino; Tiziana Fierro; Valeria Bozzi; Annamaria Mezzasoma; Patrizia Noris; Ugo Ramenghi; Giuseppe Loffredo; Fabrizio Fabris; Stefania Momi; Umberto Magrini; Mario Pirastu; Anna Savoia; Carlo Balduini; Paolo Gresele
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

5.  Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines.

Authors:  Emanuele Panza; Monica Marini; Alessandro Pecci; Francesca Giacopelli; Valeria Bozzi; Marco Seri; Carlo Balduini; Roberto Ravazzolo
Journal:  Pathogenetics       Date:  2008-12-01

6.  Genetic classification and confirmation of inherited platelet disorders: current status in Korea.

Authors:  Ye Jee Shim
Journal:  Clin Exp Pediatr       Date:  2020-02-06

7.  Rare inherited kidney diseases: an evolving field in Nephrology.

Authors:  Mariana Faucz Munhoz da Cunha; Gabriela Sevignani; Giovana Memari Pavanelli; Mauricio de Carvalho; Fellype Carvalho Barreto
Journal:  J Bras Nefrol       Date:  2020-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.